These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
876 related articles for article (PubMed ID: 16138374)
1. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers. Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374 [TBL] [Abstract][Full Text] [Related]
2. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Wu M; Wang B; Gil J; Sabo E; Miller L; Gan L; Burstein DE Am J Clin Pathol; 2003 May; 119(5):696-702. PubMed ID: 12760288 [TBL] [Abstract][Full Text] [Related]
3. p63 immunostaining in destained bronchoscopic cytological specimens. Shtilbans V; Szporn AH; Wu M; Burstein DE Diagn Cytopathol; 2005 Apr; 32(4):198-203. PubMed ID: 15754365 [TBL] [Abstract][Full Text] [Related]
4. Immunostaining for thyroid transcription factor-1 on fine-needle aspiration specimens of lung tumors: a comparison of direct smears and cell block preparations. Liu J; Farhood A Cancer; 2004 Apr; 102(2):109-14. PubMed ID: 15098255 [TBL] [Abstract][Full Text] [Related]
5. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Hecht JL; Pinkus JL; Weinstein LJ; Pinkus GS Am J Clin Pathol; 2001 Oct; 116(4):483-8. PubMed ID: 11601132 [TBL] [Abstract][Full Text] [Related]
6. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Chang YL; Lee YC; Liao WY; Wu CT Lung Cancer; 2004 May; 44(2):149-57. PubMed ID: 15084379 [TBL] [Abstract][Full Text] [Related]
7. The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears. Uke M; Rekhi B; Ajit D; Jambhekar NA Cytopathology; 2010 Feb; 21(1):56-63. PubMed ID: 19744186 [TBL] [Abstract][Full Text] [Related]
8. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens. Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169 [TBL] [Abstract][Full Text] [Related]
9. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases. Zamecnik J; Kodet R Virchows Arch; 2002 Apr; 440(4):353-61. PubMed ID: 11956814 [TBL] [Abstract][Full Text] [Related]
10. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Mukhopadhyay S; Katzenstein AL Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283 [TBL] [Abstract][Full Text] [Related]
11. Feasibility of immunocytochemical detection of tumor markers (XIAP, phosphohistone H1 and p63) in FNA cellblock samples from head and neck squamous cell carcinoma. Wu M; Kafanas A; Gan L; Kohtz DS; Zhang L; Genden E; Burstein DE Diagn Cytopathol; 2008 Nov; 36(11):797-800. PubMed ID: 18831009 [TBL] [Abstract][Full Text] [Related]
12. Fine needle aspiration biopsy versus sputum and bronchial material in the diagnosis of lung cancer. A comparative study of 168 patients. Johnston WW Acta Cytol; 1988; 32(5):641-6. PubMed ID: 2844046 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung. Whithaus K; Fukuoka J; Prihoda TJ; Jagirdar J Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical staining on fine needle aspiration biopsy-cell block specimens in the differential diagnosis of lung cancers. Kulshrestha R; Vijayan VK Indian J Chest Dis Allied Sci; 2009; 51(1):21-5. PubMed ID: 19317359 [TBL] [Abstract][Full Text] [Related]
15. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Bejarano PA; Baughman RP; Biddinger PW; Miller MA; Fenoglio-Preiser C; al-Kafaji B; Di Lauro R; Whitsett JA Mod Pathol; 1996 Apr; 9(4):445-52. PubMed ID: 8729987 [TBL] [Abstract][Full Text] [Related]
16. A study of ΔNp63 expression in lung non-small cell carcinomas. Nonaka D Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298 [TBL] [Abstract][Full Text] [Related]
17. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma. Su YC; Hsu YC; Chai CY Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563 [TBL] [Abstract][Full Text] [Related]
18. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions. Zhu W; Michael CW Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661 [TBL] [Abstract][Full Text] [Related]
19. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Agoff SN; Lamps LW; Philip AT; Amin MB; Schmidt RA; True LD; Folpe AL Mod Pathol; 2000 Mar; 13(3):238-42. PubMed ID: 10757334 [TBL] [Abstract][Full Text] [Related]
20. Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions. Dejmek A; Naucler P; Smedjeback A; Kato H; Maeda M; Yashima K; Maeda J; Hirano T Diagn Cytopathol; 2007 Aug; 35(8):493-7. PubMed ID: 17636482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]